MANAGEMENT OF HEPATITIS IN THE FEMALE.
D000970:Antineoplastic Agents; D056486:Chemical and Drug Induced Liver Injury; D003933:Diagnosis; D004032:Diet; D004035:Diet Therapy; D005260:Female; D006505:Hepatitis; D006506:Hepatitis A; D006515:Hepatitis B virus; D006939:Hyperemesis Gravidarum; D008111:Liver Function Tests; D008180:Lupus Erythematosus, Systemic; D008777:Methyltestosterone; D009640:Norethindrone; D011014:Pneumonia; D011241:Prednisone / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011704:Pyelonephritis; D013866:Thioguanine; D014116:Toxicology; D014812:Vitamin K; D005719:gamma-Globulins
D000970:Antineoplastic Agents; D005719:gamma-Globulins; D014812:Vitamin K; D013866:Thioguanine; D009640:Norethindrone; D008777:Methyltestosterone; D011241:Prednisone
ANTINEOPLASTIC AGENTS; DIAGNOSIS; DIET THERAPY; GAMMA GLOBULIN; HEPATITIS, HOMOLOGOUS SERUM; HEPATITIS, INFECTIOUS; HEPATITIS, TOXIC; HYPEREMESIS GRAVIDARUM; LIVER FUNCTION TESTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLTESTOSTERONE; NORETHINDRONE; PNEUMONIA; PREDNISONE, THERAPEUTIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYELONEPHRITIS; THIOGUANINE; TOXICOLOGIC REPORT; VITAMIN K